Articles from Glancy Prongay & Murray

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of American Oncology Network, Inc. (f/k/a Digital Transformation Opportunities Corp.) (AONC) Target Hospitality Corp. (Nasdaq: TH) (f/k/a Platinum Eagle Acquisition Corp) concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Five Below, Inc. (“Five Below” or the “Company”) (NASDAQ: FIVE) securities between March 20, 2024 to July 16, 2024, inclusive (the “Class Period”). Five Below investors have until September 30, 2024 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Equinix, Inc. (“Equinix” or the “Company”) (NASDAQ: EQIX) securities between May 3, 2019 and March 24, 2024, inclusive (the “Class Period”). Equinix investors have until July 1, 2024 to file a lead plaintiff motion.

Glancy Prongay & Murray LLP (“GPM”) announces its investigation of WillScot Mobile Mini Holdings Corp. (Nasdaq: WSC) (f/k/a Double Eagle Acquisition Corp.) concerning the Company and its directors’ and officers’ possible violations of state laws.

Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Barclays PLC (“Barclays” or the “Company”) (NYSE: BCS) American Depositary Receipts (“ADRs”) between February 18, 2021 to March 25, 2022, inclusive (the “Class Period”). Barclays investors have until November 22, 2022 to file a lead plaintiff motion.